Si-Bone yesterday registered for an initial public offering, looking to bring in approximately $97.8 million, according to an SEC filing.
The Santa Clara, Calif.-based company said that it plans to list on the Nasdaq Global Market under the ticker symbol “SIBN.”
Morgan Stanley and BofA Merrill Lynch are acting as joint book-running managers for the IPO, with Cannaccord Genuity and JMP Securities acting as co-managers, according to a press release.
The company has not yet stated how many shares it plans to list in the offering, but said that it expects to pay $12,170 in registration fees for the offering, according to an SEC filing.
Last month, Si-Bone said that France added the iFuse implant system to its List of Refundable Products and services, clearing it for reimbursement by the French National Healthcare System.